Meningococcal disease is caused by invasive infection with the bacterium Neisseria meningitidis, also known as the meningococcus.
There are 12 identified capsular groups of which groups B, C, W and Y were historically the most common in the UK.
The new MenB vaccine (Bexsero®) will protect against meningococcal disease capsular group B. The vaccine will be added to the childhood immunisation programme as part of the routine schedule in England from 1 September 2015.
Vaccine coverage estimates using a sentinel surveillance system are available